About us Öppna
Science Öppna
Investors Öppna
- Overview
Partnering Öppna
Resources & Media Öppna
Contact

Recent Coverage

Recent press coverage about Beactica Therapeutics

Catch up with the latest developments at Beactica.

2021

Beactica Therapeutics’ small molecule platform enables the efficient development of innovative drug candidates

Article in Dagens Industri Invest Talks, March 2021

Read more

2019

Moving beyond the active site: why allostery is newly in fashion

Article in BioCentury Innovations, June 21, 2019

Read more

2018

Better medicine against glioblastoma cancer

Article in SciLifeLab Synergy 2, 2018

Read more

2018

Beactica’s drug discovery platform delivers promise for brain tumour therapy

Article in SciTech Europa Quarterly 27, 2018

Read more

Stay Updated

Sign up for the Beactica newsletter to receive our latest news and updates

Beactica Therapeutics AB Uppsala Business Park Rapsgatan 7 754 50 Uppsala Sweden

+46 (0)18 56 08 80

About us Öppna
Science Öppna
Investors Öppna
- Overview
Partnering Öppna
Resources & Media Öppna
Contact

Questions?

Feel free to get in touch with your questions about our drug pipeline, unique technology or company developments using our online form. Keep up to date with our latest news through following our social media accounts.

Get in touch

© 2024 - Beactica Therapeutics AB

Policy

This website uses cookies to improve your user experience. By continuing to browse this site, you agree to our use of cookies. More information Ok